Vol. XXXVII, no. 1, 2010 ISSN: 0390-6663


CLINICAL AND EXPERIMENTAL
OBSTETRICS & GYNECOLOGY

an International Journal


Founding Editor
A. Onnis
Montréal (CND)


Editors-in-Chief
M. Marchetti
Montréal (CND)
J.H. Check
Camden, NJ (USA)


Assistant Editor
J. Wilson
San Diego - CA (USA)
Editorial Board
Audet-Lapointe P., Montréal (Canada)
Axt-Fliedner R., Lübeck (Germany)
Basta A., Krakow (Poland)
Bender H.J., Dusseldorf (Germany)
Bhattacharya N., Calcutta (India)
Bonilla Musoles F., Valencia (Spain)
Charkviani T., Tbilisi (Georgia)
Dargent D., Lyon (France)
Dexeus S., Barcelona (Spain)
Di Paola G., Buenos Aires (Argentina)
Eskes T.K.A.B.,Nijmegen (The Netherlands)
Franchi M., Verona (Italy)
Friedrich M., Homburg (Germany)
Gomel V., Vancouver (Canada)
Gorins A., Paris (France)
Holub Z., Kladno (Czech Republic)
Jordan J.A., Birmingham, England (UK)
Kaplan B., Petach Tikva (Israel)
Kralj B., Ljubljana (Slovenia)
Lalonde A.B., Ottawa (Canada)
Markowska J., Poznan (Poland)
Marth C., Innsbruck (Austria)
Meden-Vrtovec H., Ljubljana (Slovenia)
Ohara N., Kobe (Japan)
Papadopoulos N., Alexandroupolis (Greece)
Rakar S., Ljubljana (Slovenia)
Sciarra J.J., Chicago, IL (USA)
Stelmachow J., Warsaw (Poland)
Varras M.N., Athens (Greece)
Vîrtej P., Bucharest (Romania)
Winter R., Graz (Austria)

Publishing Organization (M. Morsani):
I.R.O.G. CANADA, Inc. - 4900 Côte St-Luc - Apt # 212 - Montréal, Qué. H3W 2H3 (Canada)
Tel. +514-4893242 - Fax +514-4854513 - E-mail: canlux@mgroup-online.com - http://www.irog.net/

Editorial Office (M. Critelli):
Galleria Storione, 2/A - 35123 Padua (Italy) - Tel. (39) 049 8756900 - Fax (39) 049 8752018

CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes original work, preferably brief reports, in the fields of Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology and related subjects. (Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound in Obstetrics and Gynecology, Sexually Transmitted Diseases).The Journal is covered by INDEX MEDICUS, MEDLINE, EMBASE/Excerpta Medica.

CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY is issued every three months in one volume per year by IROG CANADA Inc. Montréal. Printed in Italy by "La Garangola", Tipografia Editrice - Via E. Dalla Costa, 6 -35129 Padova (Italy).

 

Clinical and Experimental Obstetrics and Gynecology
http://www.irog.net/


General Information

CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes original peer-reviewed work, preferably brief reports, in the fields of Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology, Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound diagnosis in Obstetrics and Gynecology, Sexually transmitted diseases and related topics. It is indexed in INDEX MEDICUS, MEDLINE, EMBASE/ Excerpta Medica.

AIMS AND SCOPE
Since its inception, the CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY Journal has had the primary aim to assemble and diffuse scientific researches, particularly original researches, contributions, reviews, and proceedings of meetings in every field of the Discipline.
Today its large diffusion all over the world allows us to collect high quality papers and clinical reports on many interesting studies from every country, even from developing countries. This is the target goal of the Journal – aiming at the diffusion of knowledge and advances in female genital diseases.
This publication tries to cover all aspects of obstetrics and gynecology in an interdisciplinary approach among gynecologists, epidemiologists, pathologists, oncologists, radiologists, microbiologists, surgeons, urologists, neonatologists, genetists and so on.
The first target goal of the Journal is to publish high quality papers in the shortest time possible. Research papers, editorial reviews, case reports, technical notes, book reviews and letters to the Editor are published.

ANNOUNCEMENTS regarding meetings, postgraduate courses and symposia will be accepted 6 months before publication and will be published free of charge.
BOOK SAMPLES for review should be sent to the Editorial offices in Montréal or in Padova.
COPYRIGHT: the Journal has been registered with the Copyright Clearance Center, Inc. Reproductions are not allowed without the written consent of the Publisher. All photocopy fees should be paid to the Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA stating the ISSN number, the volume and the first and last page numbers of each article copied.
ADVERTISING INFORMATION: advertising orders and inquiries may be sent to: I.R.O.G. CANADA Inc., Publisher, 4900 Côte St. Luc, Apt. 212, Montréal (Quebec) Canada H3W 2HS, Tél. 514.4893242-4893640 - Fax 514.4854513 - E-mail: canlux@mgroup-online.com - www.irog.net
RESPONSIBILITY: although every effort is made by the editorial staff and the printer to eliminate misleading or inaccurate information, the publisher accepts no responsibility for the consequences of faultful or incorrect information. The authors recognize that the editor and publisher have no responsibility and are indemnified against any liability or claim that may result from the publication of misleading or incorrect data.

SUBSCRIPTION INFORMATION
The Journal is issued every three months (January, April, July and October); one volume per year. Subscriptions start from January and are automatically renewed if not cancelled by the end of September.
Subscriptions include four issues per year plus supplements and monographs and all official communications of Meetings, Courses, Symposia and all scientific activities in the fields of Obstetrics and Gynecology and related topics.
Subscriptions are entered with prepayment only. The annual subscription is $280 US for Institutions and $170 US for Individuals all over the world. For air mail add $20. Single copies prepaid cost $75.00 US.
Send subscription requests with cheque or credit card payment (Amex - Visa - Diners - Master Card) to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, Montréal, Québec H3W 2H3, Canada. Only US Funds are accepted.
Claims for missing issues can be honored up to six months. Changes of address: allow six weeks for all changes to become effective. All communications should include both old and new addresses (with postal codes) - better if accompanied by a mailing label from a recent issue and should be sent to the printer La Garangola, Via E. Dalla Costa, 6 - 35129 Padova (Italy) - also by Tel. +39.049.8075557, Fax +39.049.7806580. Claims should be made within six months of publication date. Duplicate copies will not be sent to replace those undelivered through failure to notify of change of address.
Single copies and back issue and volume information is available from the printer La Garangola, Padua, Tel. +39.049.8075557, Fax +39.049.7806580. Certain back issues may only be available as photocopies of the originals.
All other business correspondence including orders for offprints and advertising space and any communication and requests should be addressed to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, MONTRÉAL, QUÉBEC H3W 2H3 (Canada), Tel. (514) 4893242, fax (514) 4854513.

IN ALL LEGAL MATTERS THE COURT OF MONTREAL IS COMPETENT.




Instructions to Authors

SUBMISSION OF MANUSCRIPTS
Papers should be submitted to A. ONNIS Editor-in-Chief of the EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 4900 Côte St. Luc, Apt. 212 MONTREAL, QUÉBEC H3W 2H3 (Canada) - Tel. +514-4893242 - Fax +514-4854513, or Galleria Sto-rione 2/A - 35123 PADOVA (Italy) - Fax +39-049-8752018.

Editorial articles for publication in the "Distinguished Expert Series" should be submitted to P. Bösze, Editor-in-Chief of this section, Department of Gynecology, Saint Stephan Hospital, 1096 Budapest, Nagyvárad tér 1, Telephone (36-1) 275 2172, Fax (36-1)
275 2172, E-mail: bosze@axelero.hu

When a manuscript is submitted, an acknowledgement card is sent to the corresponding author within two or three weeks.

Submitted papers are reviewed by the Editor-in-Chief and his Peer Referees. Authors may be required to modify the manuscript according to the reviewers' suggestions.

Manuscripts accepted for publication will be copyedited by the editorial staff for typographical and grammatical mistakes and to guarantee clarity and conciseness.

Publication time will be the shortest possible based on scientific and publishing needs. Manuscripts submitted for publi-cation cannot be returned.

Published papers will become property of the Journal and copyrighted under I.R.O.G. CANADA Inc.

After six months no grievances will be accepted regarding published articles.

All statements are the responsibility of the authors. Product dosages, indications and methods referred to in the papers reflect the author's experience. No responsibility is assumed by the Editor-in-Chief or the Publisher for any damage from use of any products, operation methods or instructions contained in the published materials.

Trade names, trademarks, etc. are protected by the law and regulations. The Editor-in-Chief and the Publisher cannot accept any legal responsibility for any errors or omissions that may be made in press, particularly for information about drug dosage and appli-cation thereof contained in the Journal. Consult the prescribing information before administering any drug.

MANUSCRIPT REQUIREMENTS
The Journal follows the "Uniform requirements for manuscripts submitted to biomedical journals" published in the New England Journal of Medicine 1991, 324, 424-8 and in the British Medical Journal 1991, 302.

Three manuscripts, typed and double spaced should be submitted with an electronic disk, formatted in Word for Macintosh or Windows, version 6.0. Manuscripts without an electronic disk will not be accepted. A cover letter signed by all authors must state that all authors who have participated in the work take responsibility for the manuscript which has never been pub lished or submitted for publication elsewhere. Without a cover letter the publication will not be possible. Name, address and phone/fax numbers of the Corresponding Author, responsible for revision and approval of the proofs, should be indicated. Full-length articles should not exceed 8 printed pages including tables and references.

After the title page (full title and names of authors, institutions, eventual acknowledgement for financial support, running title of no more than 60 characters or spaces), original works should be arranged in the conventional order: Summary (purpose of investiga-tion, methods, results, conclusion - about 150 words), Key words, Content (a 20-word summary), Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement (if any), References, Tables, Legends.

Authors should supply a complete address for reprint requests.

In the text only standard abbreviations can be used and must be avoided in the title. The full term for which an abbreviation stands should precede its first use in the summary and text unless it is a standard unit of measurement.

Authors must give their complete professional identifications and affiliations, including all academic titles and positions.

Letters to the editor should be brief (500 words or less) and offer objective, constructive and educational criticism of published material. The editor reserves the right to publish.

Figures: Two original copies (not negatives) of each figure are requested. Each figure should have a label on the back indicating its number, author's name and top of the figure. Do not write on the back of the figures and do not mount them on cardboard. If sending colour pictures advise if they must be printed in colour or black and white (colour costs ten times more).

Legends should be typed on a separate page with Arabic numerals corresponding to the illustrations.

Tables should be titled, typed in double space on separate pages and numbered in Arabic numerals in the order of their first cita-tion
in the text. Do not use internal rules. Only standard, universally understood abbreviations should be used.

References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in the text, tables, and legends by Arabic numerals in parentheses.

Use the style of the examples below, which are based with slight modifications on the format used by the U.S. National Library of Medicine in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus.

References must be verified by the Author(s) against the original documents.

Examples of correct forms of references are given below:

Articles in Journals: Authors' surname and initials (if more than six names, give six followed by "et al."), Title, Abbreviated Journal Title, Year of Publication, Volume, Issue and first page.

Books: Authors' surname and initials, title of the book and title of chapter, in: Title, Editor(s), Place, Publisher, Year, Page.

Acknowledgments
will be limited to appropriate professionals who were contributors to the paper.

PROOFS revised by the editorial staff will be sent to the corresponding author and should be checked and returned within ten days. The corresponding author is responsible for detecting typesetting errors. After this deadline the proofs will be considered approved. Only essential corrections should be made; extensive changes will be charged to the authors.

BUSINESS MATTERS
The Journal has no commercial advertisements.

Authors will be expected to contribute to the printing expenses, tables, figures and postage. For every published article a copy of the Journal will be provided free of charge. Only payments in US dollars will be accepted. No bank transfers.

Reprints should be requested with the form enclosed with the acceptance letter. No free reprints will be supplied.


© By I.R.O.G. CANADA INC. - Publisher - Editorial office 4900 Côte St. Luc - Apt. 212 - Montréal Québec H3W 2H3 (Canada) - Tel. (514) 4893242-4893640 -Fax (514) 4854513 - Printed in Italy by "La Garangola" - Via E. Dalla Costa, 6 - 35129 Padua (Italy) - Responsible Director: Prof. Antonio Onnis M.D. - Authorization of Padua's Court n. 633 - 28-6-1979
 
Clinical and Experimental Obstetrics & Gynecology - Vol. XXXVII, n.1, 2010
   
EDITORIAL ARTICLES  
A practical approach to the prevention of miscarriage: Part 2 - active immunotherapy 5
J.H. Check - Camden, NJ (USA)
Lymphocyte immunotherapy has a beneficial effect in preventing miscarriage, but the paternal lymphocytes must not be refrigerated before inoculation.
 
Misoprostol for second trimester abortion in women with prior uterine incisions 10
M. Varras, Ch. Akrivis - Ioannina, GREECE
The employment of misoprostol for abortion in the second trimester of pregnancy is safe and effective.
 
 
ORIGINAL ARTICLES  
Reproductive Biology Section  
Increasing the dosage of progesterone (P) supplemention from the mid-luteal phase in women not attaining a mid-luteal homogeneous hyperechogenic (HH) pattern with sonography improves pregnancy rates (PRS) following frozen embryo transfer (ET) 13
J.H. Check, C. Dietterich, R. Cohen, J.K. Choe, J. Amui, D. Brasile - Camden, NJ (USA)
Evaluation of mid-luteal phase echo pattern in women having frozen embryo transfer revealed a trend that raising the dosage of progesterone in those not found to attain a homogeneous hyperechogenic pattern significantly improved the chance of pregnancy.
 
Successful pregnancies following embryo transfer despite very thin late proliferative endometrium 15
E. Dix, J.H. Check - Camden, NJ (USA)
Live delivered pregnancies are possible with very thin endometrium but the pregnancy rate is poor.
 
Fertilization by intracytoplasmic sperm injection with sperm with subnormal morphology using strict criteria results in lower live delivered pregnancy rates following frozen embryo transfer rather than eggs fertilized conventionally 17
J.H. Check, E. Dix, a. Bollendorf, D. Check - Camden, NJ (USA)
Fertilization of oocytes by intracytoplasmic sperm injection (ICSI) may possibly lower rather than improve the chance of successful pregnancies following frozen embryo transfer.
 
General Section  
Endometriosis: a possible cause of right shoulder pain 19
A.A. Seoud, M.M. Saleh, A.H. Yassin - Lancashire, UK
A case of chronic right shoulder pain which was found to be due to endometrosis is presented.
 
Troponin I and homocysteine levels in mild and severe preeclampsia 21
A. Atis, Y. Aydin, E. Başol, N. Göker - Istanbul, TURKEY
Homocysteine and troponin increase in cardiac events. Homocysteine increase in preeclampsia is not seen in troponin and also no correlation was found between the two
 
Preliminary results of objective assessment of mammographic percent density 24
G. Iatrakis, S. Zervoudis, P. Malakassis, I. Navrozoglou, F. Pechlivani, P. Peitsidis, P. Economides, D. Polyzos - Ioannina, GREECE
A method of objective mammographic density measurement was evaluated and a significant correlation between ACR quartiles and this method was found.
 
Correlations of fetal-maternal outcomes and first trimester 3-D placental volume/3-D power Doppler calculations 26
N. Bozkurt, A. Ba¸ sgül Yigiter, H. Gokaslan, Z.N. Kavak - Istanbul, TURKEY
3-D placental volume and blood flow calculations could be important in the prediction and easy diagnostic evaluation of IUGR.
 
Previous cesarean section increases the risk for breech presentation at term pregnancy 29

I. Kalogiannidis, N. Masouridou, T. Dagklis, S. Masoura, M. Goutzioulis, Y. Prapas, N. Prapas - Thes saloniki, GREECE
Increased risk for breech presentation in women with previous cesarean section was studied.

 
The effect of amniocentesis on preterm delivery rate in women with uterine myoma 33
S. Buyukkurt, A. Yuksel, G. Seydaoglu, R. Has, O. Kadayifci - Adana, TURKEY
A study on whether second trimester amniocentesis influences the preterm delivery rates in women with uterine myoma was carried out.
 
Prenatal diagnoses of cytomegalovirus (CMV), rubella, toxoplasmosis, varicella, parvovirus, herpes simplex and syphilis. The Lagos programme experience 37
G.O. Ajayi, S.A. Omilabu - Lagos, NIGERIA
The prenatal diagnosis of IgM seropositivity to rubella, cytomegalovirus, toxoplasmosis, varicella zoster, herpes simplex, syphilis and parvovirus in Nigerian patients is indispensable for confirm or exclude in utero infections.
 
The relationship between cardiac adaptation to uteroplacental Doppler flow and perinatal outcome in pregnant women with diabetes 39
H.A. Parlakgumus, T. Durukan - Ankara, TURKEY
In this study it was found that cardiac adaptation was normal in diabetic pregnancies.
 
Do maternity hospital practices support Greek mothers’ decision to breastfeed? 43
M. Daglas, V. Petoussi, G. Dionysiou, I. Athanassakis - Crete, GREECE
The level of adaptation and implementation of successful breastfeeding in Greek maternity hospitals was studied.
 
Effects of selective and non-selective cyclooxygenase (COX) inhibitors on postoperative adhesion formation in a rat uterine horn model 49
T. Guvenal, O. Yanar, Y. Timuroglu, M. Cetin, A. Cetin - Sivas, TURKEY
Nimesulide is more effective than celecoxib and indomethacin in the prevention of postoperative adhesion.
 
Dinoprostone vaginal insert versus intravenous oxytocin to reduce postpartum blood loss following vaginal or cesarean delivery 53
E. Ozalp, H.M. Tanir, T. Sener - Eskisehir, TURKEY
Dinoprostone vaginal insert was effective in reducing the postpartum blood loss following vaginal or cesarean delivery,
 
Psychological factors of hyperemesis gravidarum by using the SCL-90-R questionnaire 56
Z.M. Pirimoglu, K. Guzelmeric, B. Alpay, O. Balcik, O. Unal, M.C. Turan - Ankara, TURKEY
Hyperemesis gravidarum goes with psychological aspects and considering this fact helps in dealing with the problem.
 
 
CASE REPORTS  
Spontaneous uterine rupture in a nulligravida female presenting with unexplained recurrent hematometra 60
M. Gowda, L. Garcia, E. Maxwell, R. Malik, L. Gulyaeva, M.C. Tsai - New York, NY (USA)
A clinically challenging case of spontaneous uterine rupture in a nulligravida female presenting with unexplained recurrent hematometra.
 
Emergent intrauterine resuscitation in a fetus with transient congenital anemia - case report 63
N. Demir, M.T. Canda, O. Sezer - Izmir, TURKEY
A case of intrauterine fetal transfusion complicated with fetal bradycardia overcome with fetal intracardiac transfusion fol-
lowed by pericardiac tamponade and treated with pericardiocentesis.
 
Chondrosarcoma in the left hemipelvis imitating a pelvic ovarian mass in pregnancy: a case report 65

G. Somoye, S. Havenga - Norfolk, UK
Clinical presentation and management of a pelvic mass in pregnancy, presumed to be ovarian, was diagnosed as chondrosarcoma postnatally.

 
D-dimer levels as a predicting factor for DIC following single twin death: a case report and review of the literature 67
A. Daniilidis, C. Sardeli, T. Tantanasis, K. Dinas, M. Mavromichali, J. Tzafettas - Thessaloniki, GREECE
A case of intrauterine death of one twin in a diamniotic monochorionic pregnancy at 24 weeks with high level of D-dimer and normal level of other coagulation factors is reported.
 
Heterotopic pregnancy: case report 69
E. Sturlese, G. Retto, V. Palmara, A. Tripodi, M. Tripodi, M. Sorace, R. De Dominici, A. Retto - Reggio Calabria, ITALY
A case of contemporaneus intrauterine and heterotopic pregnancy is reported.
 
Idiopathic infantile arterial calcification: prenatal diagnosis and postnatal presentation 73
A. Cansu, A. Ahmetoglu, M. Mutlu, S. Guven, M.A. Osmanagaoglu - Trabzon, TURKEY
The combination of polyhydramniosis and intrauterine growth restriction may necessitate examination of the major vessels for a presumptive diagnosis of idiopathic infantile arterial calcification.